SELECT A YEAR  
> 2008
  
> 2007
  
> 2006
  
> 2005
  

> 2004

  

 
  SELECT A CITY  



  SELECT A MEETING

 
CARDIAC UPDATE
  
DIABETES FORUM
 
CARDIOVASCULAR SUMMIT
  
CARDIO-ENDOCRINE
 
OTHER
  

 









< back / SMH 2007

08:30 Welcome and Introduction Thomas Parker
I New Strategies in High Risk Prevention
Chair: Stuart Hutchinson
08:40

 Implications of the Evidence-Based Canadian Obesity Clinical Practice Guidelines to the Practicing Cardiologist

David Lau
08:55
 Aggressive Interventions: From pre-diabetes to diabetes - The role of rosiglitazone
Amir Hanna
09:10
 Global Risk Assessment:  The New Math 1+1 = 4 !
Beth Abramson
09:25

The Who, When and How of Imaging in the High Risk Asymptomatic Patient

 Michael Freeman
09:40
 Case Presentation / Panel Discussion  
10:40

II Clinical Trials In The Past Year That Impact On My Practice
Chair: Abdul Al-Hesayen
III What to do When the Plaque Ruptures
Chair: Robert Chisholm
11:10
 The Acute Coronary Syndrome (ACS) Top Ten
Shaun Goodman
11:25
 DES: Benefit or Hazard
Michael Kutryk
11:40

The Risk-Management Paradox: Are we really selecting the right patients?

Andrew Yan

11:55 Case Presentation / Panel Discussion  
12:30 - 13:30
Lunch

 
IV Improving Outcomes in Complex patients
Chair:Howard Leong-Poi
13:30
 Acute Heart Failure: New Evidence, New Guidelines

Gordon Moe

13:45
 Devices for Dummies

Victoria Korley

14:00
 What’s new in Hypertension?

Juan Carlos Monge

14:15

The Chronic Vascular Disease Management Marketplace: But who is ihe investor?

David Alter

14:30 Case Presentation / Panel Discussion  
V Debate
Chair:Thomas Parker

15:00

A Cardiologist’s Perspective: NSAID’s, including COX-2 inhibitors, are not safe

Protagonist:
David Fitchett

Antagonist:
Anatoly Langer
16:00
Conclusion and Cocktail Reception